MiMedx Group (NASDAQ:MDXG – Get Rating) had its target price increased by HC Wainwright from $8.00 to $9.50 in a report published on Wednesday, The Fly reports. HC Wainwright also issued estimates for MiMedx Group’s Q2 2023 earnings at ($0.03) EPS, Q3 2023 earnings at ($0.02) EPS, Q4 2023 earnings at $0.03 EPS, FY2023 earnings […]
Insight 2811 Inc. purchased a new stake in MiMedx Group, Inc. (NASDAQ:MDXG – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 18,032 shares of the company’s stock, valued at approximately $50,000. Several other institutional investors and hedge funds […]
MiMedx Group, Inc. (NASDAQ:MDXG – Get Rating) CFO Peter M. Carlson sold 6,094 shares of the business’s stock in a transaction on Tuesday, April 25th. The shares were sold at an average price of $3.74, for a total transaction of $22,791.56. Following the sale, the chief financial officer now directly owns 662,411 shares in the […]
MiMedx Group, Inc. (NASDAQ:MDXG – Get Rating) CFO Peter M. Carlson sold 6,094 shares of the company’s stock in a transaction dated Tuesday, April 25th. The stock was sold at an average price of $3.74, for a total value of $22,791.56. Following the completion of the transaction, the chief financial officer now owns 662,411 shares […]
MiMedx Group (NASDAQ:MDXG – Get Rating) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $8.00 price target on shares of MiMedx Group in a report on Thursday, March 2nd. […]